[Solid phase hybridization]

Area of Science:

• Molecular Biology
• Biotechnology
• Clinical Diagnostics

Background:

• Nucleic acid hybridization is a cornerstone technique in basic research for gene analysis.
• The transition of hybridization techniques to clinical biology has been hindered by limitations of previous methods.
• Advancements in non-radioactive probe technology have overcome these limitations, enabling clinical applications.

Purpose of the Study:

• To review the principles and applications of nucleic acid hybridization in clinical settings.
• To highlight the role of non-radioactive probes in advancing hybridization techniques.
• To discuss various methods for probe labeling, hybridization formats, and support materials.

Main Methods:

• Utilizing probe nucleic acid molecules to hybridize with target nucleic acid molecules, forming detectable duplexes.
• Employing non-isotopic labels (fluorescence, luminescence, enzyme activity, immuno-reactions) for probe detection.
• Performing hybridization in liquid solution with subsequent separation or on solid supports with immobilized probes or targets.

Main Results:

• Non-radioactive probes offer sensitive detection of hybridization events.
• Both liquid-phase and solid-phase hybridization formats are effective, each with distinct separation or immobilization strategies.
• A variety of solid supports, including membranes (nylon, nitrocellulose, PVDF) and microplates, are suitable for hybridization assays.

Conclusions:

• Non-radioactive nucleic acid hybridization is a powerful tool for clinical biology.
• The choice of labeling, hybridization format, and support material impacts assay performance.
• This technology facilitates sensitive and specific detection of nucleic acid targets in clinical diagnostics.